期刊文献+

Expression and Significance of fgl2 Prothrombinase in Cardiac Microvascular Endothelial Cells of Rats with Type 2 Diabetes 被引量:6

Expression and Significance of fgl2 Prothrombinase in Cardiac Microvascular Endothelial Cells of Rats with Type 2 Diabetes
下载PDF
导出
摘要 Microthrombosis may be involved in the pathogenesis of cardiac microangiopathy due to diabetes.Recent studies have shown that fibrinogen-like protein 2 (fgl2) plays a pivotal role in microthrombosis in viral hepatitis, acute vascular xenograft rejection and cytokine-induced fetal loss syndrome.The current study was designed to examine the expression of fgl2 in microvascular endothelial cells and investigate the effects of microthrombi due to fgl2 on cardiac function and structure in rats with type 2 diabetes.Following induction of type 2 diabetes, 24 rats were observed dynamically.Fgl2 expression and related cardiac microthrombosis were examined.Local or circulating TNF-α was measured.Coronary flow (CF) per min was calculated as an index of cardiac microcirculation.Cardiac function and morphology were evaluated.It was found that Fgl2 was highly expressed in cardiac microvascular endothelial cells of rats with type 2 diabetes, which was promoted by local or circulating TNF-α.The Fgl2 expression was associated with cardiac hyaline microthrombosis.In parallel with the fgl2 expression, CF per min, cardiac diastolic or systolic function and cardiac morphology were aggravated to some extent.It was concluded that in rats with type 2 diabetes, microthrombosis due to fgl2 contributes to the impairment of cardiac diastolic or systolic function and morphological changes. Microthrombosis may be involved in the pathogenesis of cardiac microangiopathy due to diabetes.Recent studies have shown that fibrinogen-like protein 2 (fgl2) plays a pivotal role in microthrombosis in viral hepatitis, acute vascular xenograft rejection and cytokine-induced fetal loss syndrome.The current study was designed to examine the expression of fgl2 in microvascular endothelial cells and investigate the effects of microthrombi due to fgl2 on cardiac function and structure in rats with type 2 diabetes.Following induction of type 2 diabetes, 24 rats were observed dynamically.Fgl2 expression and related cardiac microthrombosis were examined.Local or circulating TNF-α was measured.Coronary flow (CF) per min was calculated as an index of cardiac microcirculation.Cardiac function and morphology were evaluated.It was found that Fgl2 was highly expressed in cardiac microvascular endothelial cells of rats with type 2 diabetes, which was promoted by local or circulating TNF-α.The Fgl2 expression was associated with cardiac hyaline microthrombosis.In parallel with the fgl2 expression, CF per min, cardiac diastolic or systolic function and cardiac morphology were aggravated to some extent.It was concluded that in rats with type 2 diabetes, microthrombosis due to fgl2 contributes to the impairment of cardiac diastolic or systolic function and morphological changes.
出处 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2010年第5期575-581,共7页 华中科技大学学报(医学英德文版)
基金 supported by CGICC Medical Science Research Supporting Program (No.08010022) National Key Basic Research Program of China (No.2007CB512000,Sub-Project No.2007CB512005)
关键词 fibrinogen-like protein 2 type 2 diabetes ischemic heart disease MICROANGIOPATHY tumor necrosis factor-α cardiac function fibrinogen-like protein 2 type 2 diabetes ischemic heart disease microangiopathy tumor necrosis factor-α cardiac function
  • 相关文献

参考文献27

  • 1Waleed Aldhahi MD, FRCPC,Osama Hamdy MD, PhD.Adipokines, inflammation, and the endothelium in diabetes[J]. Current Diabetes Reports . 2003 (4)
  • 2Liu M,Mendicino M,Ning Q,et al.Cytokine-induced hepatic apoptosis is dependent on FGL2/fibroleukin:the role of Sp1/Sp3and STAT1/PU.1composite cis elements. J Immunol . 2006
  • 3Rader DJ.Inflammatory markers of coronary risk. The New England Journal of Medicine . 2000
  • 4Yagihashi S,Wada R,Yamagishi S.Diabetic microan-giopathy:pathology and current understanding of its pathogenesis. Verhandlungen der Deutschen Gesellschaft fuer Pathologie . 2002
  • 5Kohler HP,Grant PJ.Plasminogen-activator inhibitor type 1 and coronary artery disease. New England Journal of Medicine, The . 2000
  • 6Luo J,Quan J,Tsai J,et al.Nongenetic mouse models of Non-Insulin Dependent Diabetes Mellitus. Metabolism . 1998
  • 7ClarkDA,FoersterK,FungL,etal.Thefgl2prothrombinase/fi broleukingeneisrequiredforlipopolysaccharide triggeredabortionsandfor normalmousereproduction. MolHumReprod . 2004
  • 8Doolittle RF.The structure and evolution of vertebrate fibrinogen. Annals of the New York Academy of Sciences . 1983
  • 9BoeriD,MaielloM,LorenziM.Increased p revalence ofmicrothromboses in retinal cap illaries of diabetic individuals. Diabetes . 2001
  • 10Chan CW,Chan MW,Liu M,et al.Kinetic analysis of a unique direct prothrombinase,fgl2,and identification of a serine residue critical for the prothrombinase activity. J Immunol . 2002

同被引文献40

引证文献6

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部